News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MIV Therapeutics Inc. (MIVT) Announces Exchange Offer for Reg. S Shareholders in Europe



8/15/2008 8:48:30 AM

ATLANTA--(BUSINESS WIRE)--MIV Therapeutics, Inc. (OTCBB:MIVI) (Frankfurt:MIVN), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, announced today that it intends to take steps to delist its Reg. S stock from the Frankfurt Exchange. The Company’s primary market for its shares of common stock is the OTC Bulletin Board and the Company believes that the separate listing of Reg. S stock on the Frankfurt Exchange is unnecessary.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES